Background: Antimicrobial resistance is a great concern in the medical community, as well as 7 food industry. Soy peptides were tested against bacterial biofilms for their antimicrobial activity.
1 3 2 grown in 6 ml Brain Heart Infusion Broth (Thermo Scientific, Canada). Mueller Hinton broth is 1 3 3 the commonly used media for performing susceptibility tests for fast growing clinically isolated 1 3 4 bacteria. While performing preliminary experiments, it was found that L. monocytogenes did not 1 3 5 grow in Mueller Hinton broth. BHI is rich in nutrients and is suitable for fastidious organisms 1 3 6 like L. monocytogenes. Both bacteria were grown at 37°C in the respective broth until the cell 1 3 7 density was above the 0.5 McFarland barium sulfate standard, while the cells are in the 1 3 8 7 logarithmic growth phase. This inoculum was then diluted 1:140 times in the respective media. 1 3 9 100 µl of media was added to each well tested in a 96-wells microtitre plate. Then, 200 µl of 5 1 4 0 mM PGTAVFK and 2.3 mM IKAFKEATKVDKVVVLWTA soy peptide solutions were added 1 4 1 to the first well (column 1), and each row was serially diluted two-fold to column 11 of the 96-1 4 2 well microtitre plate. Column 12 was reserved for the control and did not contain any peptide 1 4 3 solution. Tests were separately carried out with the two peptides. Lactoferricin was used as 1 4 4 positive control, as it is a better-characterized peptide that has been shown to have antimicrobial 1 4 5 activity against L. monocytogenes and P. aeruginosa [32, 34] . Concentrations of lactoferricin 1 4 6 ranging from 8 µg/ml to 0.1 mg/ml have been shown to be effective against these organisms; our 1 4 7 results were consistent with these observations (data not shown). Using a pipette, 100 µl of the 1 4 8 diluted inoculum was added to all wells in the plate. A final inoculum of 4-8 × 10 5 CFU/ml was 1 4 9 achieved for each bacterial species. The final soy peptide concentrations ranged from 2.5 mM in 1 5 0 column 1 to 2.44 µM in column 11. Plates were then covered and incubated at 37°C. At 24 h, the 1 5 1 plates were taken out, and the optical density was read using a Biotrak II plate reader (Amersham 1 5 2 Biosciences, Canada). All assays were performed in triplicate. 
Microfluidic Platform
The microfluidic device was designed using AutoCAD 2015 (Autodesk Inc, USA). The 1 5 5 vision behind designing this device was to fabricate a 3D high throughput drug screening device
consisting of a glass bottom layer, a polydimethylsiloxane (PDMS) second layer with a bacterial 1 5 7 dispenser, loading channels, and 24 incubation chambers, and a final top PDMS layer with 4 1 5 8 concentration generating gradients and connective channels. The glass base was 70 mm X 70 1 5 9 mm; the central reservoir for dispensing bacteria was designed to have a diameter of 2.5 mm. The 24 incubating chambers were 2 mm in diameter, and the loading channels were 12.75 mm 1 6 1 8 long and 60 µm wide. The 4 concentration gradient generators (width = 100 µm) consisted of 8 1 6 2 inlets (each was 0.75 mm in diameter) to flow different concentrations of soy peptide with PBS 1 6 3 buffer. The gradient generators were uniformly designed to ensure that they use laminar flow and 1 6 4 diffusive mixing to form a steady mixture of PBS and peptide solution. The inlets were only 1 6 5 present on the top layer to allow for proper mixing and the flow of peptide solution. The connecting channels were about 10-15 mm in length, while the width was varied from 100 to 30 1 6 7 µm to avoid the backflow of bacteria into these channels. Once the device was designed, the 1 6 8 mask was custom made from Fine Line Imaging (Colorado, USA). From the mask, master 1 6 9 moulds were fabricated using photo-lithographic technique. The design of this 3D high 1 7 0 throughput microfluidic platform is shown in Figure 1 . were then desiccated and baked at 60°C for the PDMS mould to harden. The device was then 1 7 4 removed from the wafer, cut, and holes were punched (Harris Uni-Core, Sigma Chemical Co., 1 7 5 USA). The inlet holes on the top layer were 0.75 mm in diameter, the bacterial dispensing 1 7 6 chamber was 0.75 mm in diameter, and the 24 incubating chambers were 2 mm in diameter. Both the layers along with the glass base were plasma cleaned (Harrick Plasma, Ithaca, USA) to 1 7 8 remove debris and to enhance the bonding between various layers. Then, the layers were 1 7 9 assembled and baked at 60°C for 30 minutes to strengthen the bond. The top view of the microfluidic platform and a magnified view of the complete CGG with 1 8 8 gradient generated by the soy peptide and buffer solution at the end of the generator. The fabricated 3D microfluidic device was characterized using fluorescein dye (Sigma Aldrich, Canada). This test was performed to ensure that the CGG generated steadily or linearly prepared in water. A 5 µM solution was prepared from this stock and injected in one of the inlets 1 9 5 of a CGG along with water at the other inlet of CGG. Syringe pumps were used for controlled 1 9 6 injection (20 µl/h) of water and fluorescein dye into the CGG (Chemyx Fusion Touch, USA) 1 9 7 through a 1 mm syringe and 0.3 mm needle tips (Becton, Dickinson and Company, USA). Images were taken using an inverted Nikon Eclipse Ti microscope with a green filter. Images 1 9 9
were processed using ImageJ software (NIH, USA). Standard and used for further experimentation to ensure that cells would be poised to grow once 2 0 7 inoculated. The cells were injected into the bacterial dispensing chamber at the center of the device was maintained at 37°C using a temperature controller stage. Once the concentration 2 1 4 gradients start to fill and the 24 wells were filled with the peptide and bacterial mixture, the 2 1 5 syringe pumps were turned off and the bacteria were incubated in the device. RAMAN Spectroscopy was used in identifying P. aeruginosa and L. monocytogenes 2 1 8 before and after various treatments with long chain peptides. This was done to emphasize that the 2 1 9 spectral signature of the bacteria and peptide mixture at different dosage levels could be used to 2 2 0 validate the high throughput drug screening microfluidic device and show the efficacy of 2 2 1 peptides against bacteria. P. aeruginosa and L. monocytogenes visually significant peaks or differences compared to the peptide treated bacterial samples (data 2 2 8 not shown). Ampicillin was used as a control in this experiment. Instruments Inc., Melville, NY). A total 10 µl of the solution ensured that the individual bacterial 2 3 5 cells were exposed to sufficient volumes of media. Images were captured focusing on the same enzyme that has the ability to catalyze the production of phospholipids during salvage. Inositol is 2 5 4 a metabolic sensor for numerous signal transduction pathways that specifically has the ability to Therefore PGTAVFK and IKAFKEATKVDKVVVLWTA were chosen as antimicrobial peptide candidates for this study. 
Antimicrobial Testing Using Microdilution Assay
Microdilution assays were performed to examine the antimicrobial efficacy of both short 2 6 1 chain (PGTAVFK) and long chain (IKAFKEATKVDKVVVLWTA) soy peptides against P. inhibitory effect on L. monocytogenes at a concentration above 625 µM. IKAFKEATKVDKVVVLWTA, on the other hand, was effective against both P. aeruginosa and 2 6 8 L. monocytogenes at concentrations above 37.2 µM. It is apparent from our results that both 2 6 9
antimicrobial peptides can affect the optical density of the organisms, which represents the 2 7 0 concentration of the suspended organisms and the sum total of growth and cell death. Therefore, 2 7 1 we cannot speculate whether the major modes of actions for these peptides are bactericidal 2 7 2 versus bacteriostatic; future studies will explore the precise mechanisms of action. L. monocytogenes C379. The soy peptide did not inhibit the bacterial growth of P. aeruginosa 2 7 6 significantly but had an inhibitory effect on L. monocytogenes at concentrations above 625 µM. The difference in antimicrobial efficacy between the short and long chain peptides could 3 0 1 be attributed to the structure and length of the sequences (7 amino acid sequence: PGTAVFK; 19 3 0 2 amino acid sequence: IKAFKEATKVDKVVVLWTA). As discussed previously, long chain and anions present in their environment [12] . Therefore, the combination of amino acids in the 3 0 7
sequences of peptides could have affected their antibacterial efficacy.
0 8
It has been demonstrated that some cations neutralize repulsive forces of adjacent a reason why the long chain peptide was able to act effectively on P. aeruginosa, while the short 3 1 3
chain peptide was largely inactive [26] . This could also be the reason why PGTAVFK was not 3 1 4
able to significantly inhibit P. aeruginosa but was able to inhibit L. monocytogenes, a Gram- membrane comprised of phospholipids on both sides of the bilayer. Therefore, a peptide that 3 1 7 could enter the outer membrane need not necessarily interact efficiently with the inner 3 1 8
membrane. It has been reported that peptides form aggregates in solution, which makes it 3 1 9
difficult for them to enter the outer membrane and reach the target, which is the cytoplasmic and toxic. Therefore, dissociation of these aggregates is required to neutralize and inactivate 3 2 3
LPS. These could be some plausible reasons for the observed differential sensitivity. 
Characterization of our High Throughput 3D Microfluidic Platform
Characterization of the 3D microfluidic device was performed to show that this device 3 2 6 could be used for multiplexing, parallel concentration gradient generation, and drug screening 3 2 7
applying various concentrations simultaneously. Moreover, the use of PDMS helps in creating an inexpensive, biocompatible, and transparent environment that allows the use of this device in 3 2 9
further quantification through optical and RAMAN imaging.
Under continuous flow conditions, the 3D high throughput device was characterized 3 3 1 using 5 µM fluorescein dye. Figure 4 shows the concentration gradient formed in the six inverted microscope, and the intensity of fluorescence was then measured from 6 channels and 3 3 5
normalized. We found that the fluorescence intensity increases with increasing channel number. previous studies [7, 16] . 
RAMAN Spectra Analysis
3 5 1 RAMAN spectroscopy is a preferred tool for identifying and detecting pathogens for food industry and medical field. peptides: Form follows function. Nature Reviews Drug Discovery, 11(1), 37-51. Vibrational Spectroscopy-based Sensor Systems, 182 (February 13, 2002) . Conservation, regulation, and putative target of mood stabilizers. Clinical Neuroscience 5 1 8
Research, 4(3-4), 181-187. 
